Authors: Rothman, AL Kanesa-thasan, N West, K Janus, J Saluzzo, JF Ennis, FA

Citation: Al. Rothman et al., Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine, VACCINE, 19(32), 2001, pp. 4694-4699

Authors: Kanesa-thasan, N Sun, W Kim-Ahn, G Van Albert, S Putnak, JR King, A Raengsakulsrach, B Christ-Schmidt, H Gilson, K Zahradnik, JM Vaughn, DW Innis, BL Saluzzo, JF Hoke, CH

Citation: N. Kanesa-thasan et al., Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers, VACCINE, 19(23-24), 2001, pp. 3179-3188

Authors: Houng, HSH Chen, RCM Vaughn, DW Kanesa-thasan, N

Citation: Hsh. Houng et al., Development of a fluorogenic RT-PCR system for quantitative identificationof dengue virus serotypes 1-4 using conserved and serotype-specific 3 ' noncoding sequences, J VIROL MET, 95(1-2), 2001, pp. 19-32

Authors: Kanesa-thasan, N Smucny, JJ Hoke, CH Marks, DH Konishi, E Kurane, I Tang, DB Vaughn, DW Mason, PW Shope, RE

Citation: N. Kanesa-thasan et al., Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune andvaccinia-immune humans, VACCINE, 19(4-5), 2000, pp. 483-491

Authors: Houng, HSH Hritz, D Kanesa-thasan, N

Citation: Hsh. Houng et al., Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on3 '-noncoding sequence, J VIROL MET, 86(1), 2000, pp. 1-11